Literature DB >> 20001619

Prevention of hemoglobinopathies in Egypt.

Amal El-Beshlawy1, Ilham Youssry.   

Abstract

The hemoglobin disorders are the most common clinically serious single gene disorders in the world. In Egypt, beta-thalassemia is the most common type with a carrier rate varying from 5.3 to > or =9% and a gene frequency of 0.03. So, it was estimated that 1,000/1.5 million per year live births will suffer from thalassemia disease in Egypt (total live births 1,936,205 in 2006). beta-Thalassemia creates a social and financial burden for the patients' family and the Egyptian government. The high frequency of beta-thalassemia carriers with increasing rate of newly born cases is a pressing reason for the importance to develop prevention program for beta-thalassemia in Egypt. Sickle-cell disease (SCD) is not frequent in Egypt except in the Oases where the carrier rate varies from 9 to 22%. Our objectives were to provide an in-depth analysis of the current status of hemoglobinopathies in Egypt and what we need for prevention of these diseases.

Entities:  

Mesh:

Year:  2009        PMID: 20001619     DOI: 10.3109/03630260903346395

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  13 in total

1.  Epidemiological profile of common haemoglobinopathies in Arab countries.

Authors:  Hanan A Hamamy; Nasir A S Al-Allawi
Journal:  J Community Genet       Date:  2012-12-08

2.  Ocular manifestations in egyptian children and young adults with sickle cell disease.

Authors:  Mona Kamal El-Ghamrawy; Hanan F El Behairy; Amal El Menshawy; Seham A Awad; Ahmed Ismail; Mohamed Salah Gabal
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-23       Impact factor: 0.900

3.  Association of VDBP rs4701 Variant, but not VDR/RXR-α Over-Expression with Bone Mineral Density in Pediatric Well-Chelated β-Thalassemia Patients.

Authors:  Shaimaa Sahmoud; Mostafa S Ibrahim; Eman A Toraih; Noha Kamel; Manal S Fawzy; Samar Elfiky
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-07-01       Impact factor: 2.576

4.  Accuracy of Reverse Dot-Blot PCR in Detection of Different β-Globin Gene Mutations.

Authors:  N El-Fadaly; A Abd-Elhameed; E Abd-Elbar; M El-Shanshory
Journal:  Indian J Hematol Blood Transfus       Date:  2015-05-27       Impact factor: 0.900

Review 5.  Sickle cell disease in Middle East Arab countries.

Authors:  Mohsen A F El-Hazmi; Ali M Al-Hazmi; Arjumand S Warsy
Journal:  Indian J Med Res       Date:  2011-11       Impact factor: 2.375

Review 6.  Genetic epidemiology and preventive healthcare in multiethnic societies: the hemoglobinopathies.

Authors:  Piero C Giordano; Cornelis L Harteveld; Egbert Bakker
Journal:  Int J Environ Res Public Health       Date:  2014-06-11       Impact factor: 3.390

7.  Spectrum of Beta Globin Gene Mutations in Egyptian Children with β-Thalassemia.

Authors:  Mr El-Shanshory; Aa Hagag; Ss Shebl; Im Badria; Ah Abd Elhameed; Es Abd El-Bar; Y Al-Tonbary; A Mansour; H Hassab; M Hamdy; M Alfy; L Sherief; E Sharaf
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

8.  Prevalence of Xmnl Gγ polymorphism in Egyptian patients with β-thalassemia major.

Authors:  Azza A G Tantawy; Nevine G Andrawes; Amany Ismaeil; Solaf A Kamel; Wessam Emam
Journal:  Ann Saudi Med       Date:  2012 Sep-Oct       Impact factor: 1.526

9.  Urban Egyptian Women Aged 19-30 Years Display Nutrition Transition-Like Dietary Patterns, with High Energy and Sodium Intakes, and Insufficient Iron, Vitamin D, and Folate Intakes.

Authors:  Chloé M C Brouzes; Nicolas Darcel; Daniel Tomé; Maria Carlota Dao; Raphaëlle Bourdet-Sicard; Bridget A Holmes; Anne Lluch
Journal:  Curr Dev Nutr       Date:  2020-01-06

10.  The relationships between pancreatic T2* values and pancreatic iron loading with cardiac dysfunctions,  hepatic and cardiac iron siderosis among Egyptian children and young adults with β-thalassaemia major and sickle cell disease: a cross-sectional study.

Authors:  Khaled Salama; Amina Abdelsalam; Hadeel Seif Eldin; Eman Youness; Yasmeen Selim; Christine Salama; Gehad Hassanein; Mohamed Samir; Hanan Zekri
Journal:  F1000Res       Date:  2020-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.